Melevodopa
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
methyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate | |
| Identifiers | |
| CAS Number | 7101-51-1 |
| ATC code | N04BA04 (WHO) |
| PubChem | CID 23497 |
| ChemSpider |
21968 |
| UNII |
M30686U4X4 |
| KEGG |
D07304 |
| Chemical data | |
| Formula | C10H13NO4 |
| Molar mass | 211.215 g/mol |
| |
| |
| (verify) | |
Melevodopa (brand name Levomet) is a dopaminergic agent. It is the methyl ester of levodopa. It is used in tablet form as an effervescent prodrug with 250 times higher water solubility compared to tablet levodopa.[1]
See also
References
- ↑ Patrick Hickey and Mark Stacy (2011). "Available and emerging treatments for Parkinson’s disease". Drug Des Devel Ther 5: 241–254. doi:10.2147/DDDT.S11836. PMC 3096539. PMID 21607020.
| ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
